Litcius/Paper detail

Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial

Simon Mark Dahl Baunwall, Sara Ellegaard Andreasen, Mette Mejlby Hansen, Jens Kelsen, Katrine Lundby Høyer, Nina Rågård, Lotte Lindgreen Eriksen, Sidsel Støy, Tone Rubak, Else Marie Skjøde Damsgaard, Susan Mikkelsen, Christian Erikstrup, Jens Frederik Dahlerup, Christian Lodberg Hvas

2022˜The œLancet. Gastroenterology & hepatology123 citationsDOI

Topics & Concepts

ClostridioidesPlaceboFecal bacteriotherapyMedicineInternal medicineDouble blindTransplantationRandomized controlled trialClostridium difficileBiologyMicrobiologyAntibioticsPathologyAlternative medicineClostridium difficile and Clostridium perfringens researchGut microbiota and healthAntibiotic Use and Resistance
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial | Litcius